Publications by authors named "Tracey Ross"

Claim this Profile
A
Atypical presentation of sinonasal cellular schwannoma: a nonsolitary mass with osseous, orbital, and intracranial invasion.
John Gencarelli, Ryan Rourke, Tracey Ross, Denis H Gravel, Bibianna Purgina

J Neurol Surg Rep· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of peripheral artery disease: an unmet medical need.
W Ross Tracey, Delvin R Knight

Curr Opin Investig Drugs· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter by Tracey regarding article, "Bypassing big pharma".
W Ross Tracey

Circulation· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The A3 adenosine receptor agonist CP-532,903 [N6-(2,5-dichlorobenzyl)-3'-aminoadenosine-5'-N-methylcarboxamide] protects against myocardial ischemia/reperfusion injury via the sarcolemmal ATP-sensitive potassium channel.
Tina C Wan, Zhi-Dong Ge, Akihito Tampo, Yasushi Mio, Martin W Bienengraeber, W Ross Tracey, Garrett J Gross

J Pharmacol Exp Ther· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Niche drugs aren't a cheap alternative to blockbusters.
W Ross Tracey

Nature· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The synthesis of highly potent, selective, and water-soluble agonists at the human adenosine A3 receptor.
Michael P DeNinno, Hiroko Masamune, Lois K Chenard, Kenneth J DiRico, Cynthia Eller, W Ross Tracey

Bioorg Med Chem Lett· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Issues in bringing new drugs to the market.
W Ross Tracey

Science· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The sulfonylurea glipizide does not inhibit ischemic preconditioning in anesthetized rabbits.
David M Flynn, Andrew H Smith, Judith L Treadway, Carolyn B Levy, Walter C Soeller, W Ross Tracey

Cardiovasc Drugs Ther· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harbinger for the era of personalized medicine?
W Ross Tracey

Mol Interv· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardioprotective efficacy of zoniporide, a potent and selective inhibitor of Na+/H+ exchanger isoform 1, in an experimental model of cardiopulmonary bypass.
Hugh Clements-Jewery, Fiona J Sutherland, Mary C Allen, W Ross Tracey, Metin Avkiran

Br J Pharmacol· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardioprotective effects of ingliforib, a novel glycogen phosphorylase inhibitor.
W Ross Tracey, Judith L Treadway, William P Magee, Jill C Sutt, R Kirk McPherson

Am J Physiol Heart Circ Physiol· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel N6-substituted adenosine 5'-N-methyluronamides with high selectivity for human adenosine A3 receptors reduce ischemic myocardial injury.
W Ross Tracey, William P Magee, Joseph J Oleynek, Roger J Hill, Andrew H Smith

Am J Physiol Heart Circ Physiol· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isozyme-nonselective N-substituted bipiperidylcarboxamide acetyl-CoA carboxylase inhibitors reduce tissue malonyl-CoA concentrations, inhibit fatty acid synthesis, and increase fatty acid oxidation in cultured cells and in experimental animals.
H James Harwood, Stephen F Petras, Lorraine D Shelly, Lawrence M Zaccaro, David A Perry, W Ross Tracey

J Biol Chem· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zoniporide: a potent and selective inhibitor of the human sodium-hydrogen exchanger isoform 1 (NHE-1).
W Ross Tracey, Mary C Allen, Donald E Frazier, Anthony A Fossa, Celeste G Johnson

Cardiovasc Drug Rev· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differing cardioprotective efficacy of the Na+/Ca2+ exchanger inhibitors SEA0400 and KB-R7943.
William P Magee, Gayatri Deshmukh, Michael P Deninno, Jill C Sutt, Justin G Chapman, W Ross Tracey

Am J Physiol Heart Circ Physiol· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3'-Aminoadenosine-5'-uronamides: discovery of the first highly selective agonist at the human adenosine A3 receptor.
Michael P DeNinno, Hiroko Masamune, Lois K Chenard, Kenneth J DiRico, Cynthia Eller, W Ross Tracey

J Med Chem· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel nonpeptidic caspase-3/7 inhibitor, (S)-(+)-5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatin reduces myocardial ischemic injury.
Justin G Chapman, William P Magee, Hans A Stukenbrok, Gretchen E Beckius, Anthony J Milici, W Ross Tracey

Eur J Pharmacol· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zoniporide: a potent and highly selective inhibitor of human Na(+)/H(+) exchanger-1.
Ravi B Marala, Janice A Brown, Jimmy X Kong, W Ross Tracey, Delvin R Knight

Eur J Pharmacol· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence for the involvement of CYP1A2 in the metabolism of bromodichloromethane in rat liver.
John W Allis, Brian P Anderson, Guangyu Zhao, Tracey M Ross, Rex A Pegram

Toxicology· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis